what glp-1 has the least side effects Your guide to Understanding GLP-1 side effects

Lancet Diabetes Endocrinol 10(6):418429

States must cover this indication

It was granted in June 1995 (Eng

Combination requires baseline hepatic screening, regular monitoring, and careful interaction assessment

In addition to their established benefits for the management of diabetes and obesity, GLP-1RAs have shown potential in managing MASLD through mechanisms such as reducing hepatic lipogenesis, improving insulin sensitivity, and modulating inflammation

Competing interests PG has received occasional fees, either personally or institutionally, for the activities of speaking, scientific advising, or clinical research from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Merck Sharp & Dohme, Novo Nordisk, Organon, Pfizer, and Sanofi